Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Are Intranasal Sprays The Next $36 Billion Trend in Vaccine Stocks?
Are Intranasal Sprays The Next $36 Billion Trend in Vaccine Stocks?
Are Intranasal Sprays The Next $36 Billion Trend in Vaccine Stocks?
Submitted by
admin
on February 8, 2022 - 9:56am
Source:
Motley Fool
News Tags:
vaccines
AstraZeneca
intranasal vaccines
Headline:
Are Intranasal Sprays The Next $36 Billion Trend in Vaccine Stocks?
snippet:
Injectable coronavirus vaccines work to prevent severe disease, but they aren't perfect.
Intranasal vaccines may not have the same drawbacks as jabs.
AstraZeneca is already working to make an intranasal version of its coronavirus vaccine.
Do Not Allow Advertisers to Use My Personal information
